Check out our most popular compounded medications! Get Started
Selegiline HCl Oral Suspension is a compounded formulation with a concentration of 1 mg/0.05 ml. This homogeneous liquid mixture is used for the treatment of various neurological and mental health conditions such as Parkinson's Disease, Depression, Alzheimer's Disease, Bipolar Disorder, and Schizophrenia.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to offer Selegiline HCl 1 mg/0.05 ml Oral Suspension, a compounded formulation designed for the treatment of various neurological and psychiatric conditions such as Parkinson's Disease, Depression, Alzheimer's Disease, Bipolar Disorder, and Schizophrenia. Selegiline is a monoamine oxidase inhibitor (MAOI) that functions by enhancing the levels of certain neurotransmitters in the brain, including dopamine, norepinephrine, and serotonin. This mechanism of action aids in mood improvement, anxiety reduction, and cognitive function enhancement.
Selegiline has demonstrated efficacy in managing the symptoms associated with Parkinson's Disease, Depression, Alzheimer's Disease, Bipolar Disorder, and Schizophrenia. The Selegiline HCl 1 mg/0.05 ml Oral Suspension is a liquid dosage form in which the active ingredient is uniformly dispersed throughout a liquid medium, providing a homogeneous mixture for oral administration. This formulation is convenient and easy to use, making it an ideal choice for patients who may have difficulty swallowing pills or tablets.
It is crucial to note that Selegiline HCl 1 mg/0.05 ml Oral Suspension should not be co-administered with certain other medications, such as specific antidepressants, due to the potential for serious side effects. Additionally, patients should be informed that Selegiline HCl 1 mg/0.05 ml Oral Suspension may induce drowsiness, and therefore caution should be exercised when operating machinery or driving.
If you have any inquiries about Selegiline HCl 1 mg/0.05 ml Oral Suspension or its use in the treatment of Parkinson's Disease, Depression, Alzheimer's Disease, Bipolar Disorder, or Schizophrenia, please do not hesitate to contact us at Bayview Pharmacy. Our team is committed to providing comprehensive information and support to ensure optimal patient care and treatment outcomes.
This compounded formulation of Selegiline HCl 1 mg/0.05 ml Oral Suspension is a liquid dosage form that provides a homogeneous mixture for administration. It is primarily used in the treatment of various neurological and psychiatric conditions such as Parkinson's Disease, Depression, Alzheimer's Disease, Bipolar Disorder, and Schizophrenia. Selegiline, the active ingredient, is a monoamine oxidase inhibitor (MAOI) that functions by increasing the levels of certain neurotransmitters in the brain, including dopamine, norepinephrine, and serotonin.
It is crucial to understand that Selegiline should not be used in conjunction with other MAOIs due to the risk of serious side effects. Furthermore, certain medications, including tricyclic antidepressants, SSRIs, and specific antipsychotics, should not be combined with Selegiline. Patients should be informed about the potential side effects of Selegiline, which may include drowsiness, dizziness, and confusion. As a result, patients should refrain from driving or operating heavy machinery until they fully understand how the medication affects them.
It is always recommended to consult with a healthcare provider or pharmacist before starting any new medication, including this formulation of Selegiline HCl 1 mg/0.05 ml Oral Suspension. They can provide comprehensive information about the medication, its potential interactions, and how to manage any side effects. Always follow the prescribed dosage and administration instructions to ensure the medication's effectiveness and safety.
Selegiline HCl 1 mg/0.05 ml Oral Suspension is a compounded medication that is used in the treatment of various neurological and psychiatric conditions. These conditions include Parkinson's Disease, Depression, Alzheimer's Disease, Bipolar Disorder, and Schizophrenia. The medication functions by inhibiting the breakdown of dopamine, a neurotransmitter that is integral to movement, cognition, and emotion.
The oral suspension form of Selegiline HCl 1 mg/0.05 ml ensures a uniform dispersion of the active ingredient in a liquid medium, providing a homogeneous mixture for administration. This form of medication is typically taken once daily, either in the morning or evening, depending on the patient's individual needs. It is crucial to adhere to the prescribed dosage and not to alter the dose or frequency without consulting a healthcare professional.
Common side effects of Selegiline HCl 1 mg/0.05 ml Oral Suspension include nausea, dizziness, insomnia, and headache. Patients are advised to contact their healthcare provider if they experience any of these side effects or if they have any questions or concerns about the medication.
If you have any questions or concerns about Selegiline HCl 1 mg/0.05 ml Oral Suspension, it is recommended to reach out to a healthcare professional for further information and guidance.
Selegiline HCl 1 mg/0.05 ml Oral Suspension is a liquid dosage form of the medication Selegiline. It is designed to be taken orally, with the active ingredient dispersed uniformly throughout a liquid medium to provide a homogeneous mixture for administration.
Selegiline HCl 1 mg/0.05 ml Oral Suspension should be taken orally as directed by your healthcare provider. The liquid should be shaken well before each use to ensure the medication is evenly distributed.
The liquid medium in this formulation serves to evenly distribute the active ingredient, Selegiline, ensuring that each dose contains the correct amount of medication.
'1 mg/0.05 ml' refers to the concentration of Selegiline in the suspension. This means that there is 1 milligram of Selegiline in every 0.05 milliliters of the suspension.
It's important to follow your healthcare provider's instructions regarding this. Some medications can interact with certain foods or drinks, altering their effectiveness or causing side effects.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
If you accidentally take more than the recommended dose, seek medical attention immediately. Overdosing can lead to serious health consequences.
No, you should continue taking the medication for the full course of treatment, even if you feel better, unless instructed otherwise by your healthcare provider. Stopping the medication early may allow the condition to return or worsen.
Side effects can vary from person to person and may include nausea, dry mouth, or lightheadedness. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
Always consult your healthcare provider before taking any medication if you are pregnant or breastfeeding. They will be able to advise you on the potential risks and benefits.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
